Wave Life Sciences Ltd. (WVE) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.618 Hello, and welcome to Wave Life Sciences' first quarter 2026 earnings call. 00:00:05.618 -- 00:00:09.703 We ask that you please hold all questions until the completion of the formal remarks, 00:00:09.703 -- 00:00:13.308 at which time you'll be given instructions for the question and answer session. 00:00:13.308 -- 00:00:16.892 Also, as a reminder, this conference call is being recorded today. 00:00:16.892 -- 00:00:20.357 I will now turn the call over to Kate Roush, Vice President of Corporate Affairs and 00:00:20.357 -- 00:00:22.717 Investor Relations. 00:00:22.897 -- 00:00:25.720 Thank you, Operator, and good morning to everyone on the call. 00:00:25.720 -- 00:00:30.146 Earlier this morning, we issued a press release outlining our first quarter 2026 earnings 00:00:30.146 -- 00:00:33.029 update. Joining me today with prepared remarks are Dr. 00:00:33.029 -- 00:00:36.012 Paul Bono, President and Chief Executive Officer, Dr. 00:00:36.012 -- 00:00:38.956 Eric Engelson, Chief Scientific Officer, Dr. 00:00:38.956 -- 00:00:43.001 Chris Wright, Chief Medical Officer, and Kyle Moran, Chief Financial Officer. 00:00:43.001 -- 00:00:46.645 The press release issued this morning is available on the investor section of our website, 00:00:46.645 -- 00:00:48.645 www.wavelifesciences.com. 00:00:49.711 -- 00:00:53.116 Before we begin, I would like to remind you that discussions during this conference call 00:00:53.116 -- 00:00:56.982 will include forward-looking statements. These statements are subject to several risks 00:00:56.982 -- 00:01:00.568 and uncertainties that could cause our actual results to differ materially from those 00:01:00.568 -- 00:01:02.751 described in these forward-looking statements. 00:01:02.751 -- 00:01:06.177 The factors th...